Janux therapeutics announces first patient dosed with janx007 in first-in-human phase 1 clinical trial in patients with prostate cancer

San diego--(business wire)---- $janx--janux therapeutics announces first patient dosed with janx007 in first-in-human phase 1 clinical trial in patients with prostate cancer

JANX Ratings Summary

JANX Quant Ranking